English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Objective:  To test the psychometric properties, internal consistency, dimensional structure, and convergent validity of the German version of the Demoralization Scale-II (DS-II), and to examine the association between demoralization, sociodemographic, disease- and treatment-related variables in patients with cancer.   Methods:  We recruited adult patients with cancer at a Psychosocial Counseling Center and at oncological wards. Participants completed the 16-item DS-II, Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder Screener-2 (GAD-2), Distress Thermometer (DT), and Body Image Scale (BIS). We analyzed internal consistency of the DS-II using Cronbach‘s Alpha (α). We tested the dimensional structure of the DS-II with Confirmatory Factor Analyses (CFA). Convergent validity was expressed through correlation coefficients with established measures of psychological distress. The associations between demoralization, sociodemographic, disease- and treatment-related variables were examined with ANOVAs.   Results:  Out of 942 eligible patients, 620 participated. The average DS-II total score was  M  = 5.78,  SD  = 6.34, the  Meaning and Purpose  subscale  M  = 2.20,  SD  = 3.20, and the  Distress and Coping Ability  subscale  M  = 3.58,  SD  = 3.45. Internal consistency ranged from high to excellent with α = 0.93 for the DS-II total scale, α = 0.90 for the  Meaning and Purpose  subscale, and α = 0.87 for the  Distress and Coping Ability  subscale. The one-factor and the two-factor model yielded similar model fits, with CFI and TLI ranging between 0.910 and 0.933, SRMR &amp;lt; 0.05. The DS-II correlated significantly with depression (PHQ-9:  r  = 0.69), anxiety (GAD-2:  r  = 0.72), mental distress (DT:  r  = 0.36), and body image disturbance (BIS:  r  = 0.58). High levels of demoralization were reported by patients aged between 18 and 49 years ( M  = 7.77,  SD  = 6.26), patients who were divorced/separated ( M  = 7.64,  SD  = 7.29), lung cancer patients ( M  = 9.29,  SD  = 8.20), and those receiving no radiotherapy ( M  = 7.46,  SD  = 6.60).   Conclusion:  The DS-II has very good psychometric properties and can be recommended as a reliable tool for assessing demoralization in patients with cancer. The results support the implementation of a screening for demoralization in specific risk groups due to significantly increased demoralization scores.

frontiers in psychology

Psychometric Evaluation of the German Version of the Demoralization Scale-II and the Association Between Demoralization, Sociodemographic, Disease- and Treatment-Related Factors in Patients With Cancer